OSCR.NYSEOscar Health, INC

Form 4: Oscar Health EVP Alessandrea C. Quane Reports Stock Transactions

Sentiment:

SEC Form 4

📋All filings for Oscar Health, INC
🔒Login to Follow

Alessandrea C. Quane, EVP and Chief Insurance Officer at Oscar Health, reported the acquisition and disposal of Class A Common Stock and Restricted Stock Units on March 1 and March 4, 2024.

Summary

  • Alessandrea C. Quane, EVP and Chief Insurance Officer of Oscar Health, reported transactions involving Class A Common Stock and Restricted Stock Units.
  • On March 1, 2024, Quane acquired 7,015 and 34,380 shares of Class A Common Stock through the vesting of Restricted Stock Units.
  • Also on March 1, 2024, 7,015 and 34,380 Restricted Stock Units vested.
  • On March 4, 2024, Quane disposed of 15,928 shares of Class A Common Stock at a weighted average price of $15.88.
  • Following these transactions, Quane directly owns 194,833 shares of Class A Common Stock and indirectly owns 76,857 shares through a GRAT.
  • Quane also directly owns 42,095 and 412,555 Restricted Stock Units after the reported transactions.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, reflecting routine stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
  • The sale of shares is related to tax obligations from vesting equity awards, which is a normal part of executive compensation.

Key Dates

DateDescription
12/01/2021Start date for vesting of 7,015 restricted stock units over a four-year period in 16 equal quarterly installments
02/27/2023Date prior to which a Rule 10b5-1 instruction letter was entered into.
06/01/2023Start date for vesting of 34,380 restricted stock units over a four-year period in 16 equal quarterly installments
03/01/2024Vesting of 7,015 and 34,380 Restricted Stock Units and acquisition of corresponding Class A Common Stock.
03/04/2024Sale of 15,928 shares of Class A Common Stock.
03/05/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.